DERM · PRE-MALIGNANT LESIONS

Actinic Keratosis

The sun's receipt. Years of UV damage, stored as a rough scaly patch on sun-exposed skin. Ignore it and it might cash in as squamous cell carcinoma.

Pre-Malignant · 5-10% SCC Risk · UV-Induced p53 Mutation

The Patient

Don't look at the answer yet. Just read.

A 66-year-old landscaper comes in with a 4-month history of recurrent crusty patches on the backs of his hands. He describes them as rough, like sandpaper with a peeling, adherent scale that comes back whenever he picks it off. Occasionally they itch and burn. He's worked outdoors without sunscreen for 30 years.

Photograph shows multiple erythematous patches with an adherent yellowish-white scale, concentrated on the dorsal hands. No rolled edges, no pearly border, no dark pigment.

What's the most likely diagnosis, and what's the one thing you don't want to miss about it?

The answers are woven into everything below. Keep going and earn them.

What Is Actinic Keratosis?

Start here before anything else

Actinic keratosis on the scalp showing rough scaly patches
📷 AK on scalp · tap to expand

Actinic keratosis (AK) is a pre-malignantNot cancer yet. But it's standing in the cancer waiting room. The cells are abnormal but haven't punched through the basement membrane yet. skin lesion caused by cumulative UVB radiation damage to keratinocytes.

Think of it like this: every unprotected sun exposure is a tiny mutation stored in your DNA. After 30 years of landscaping without sunscreen, those mutations pile up. AK is the skin's way of saying "the bill is coming due."

The key word is cumulative. This isn't about one bad sunburn. This is decades of UV exposure quietly damaging the same keratinocytes on the same sun-exposed areas, over and over, until the DNA can't keep up.

⚠️ AK is not cancer, but 5-10% of untreated AKs progress to invasive squamous cell carcinoma if left alone. That's the one you don't want to miss.

UVB Destroys the Skin's Editor

p53 is what catches and fixes DNA errors. UV breaks it.

UVB radiation causes a very specific type of DNA damage: it fuses adjacent thymine bases together (called pyrimidine dimersTwo adjacent thymines (T-T) stuck together by UV energy. The DNA proofreader can't read it correctly. If p53 is also broken, the cell divides with this error baked in.). Normally your cells catch these errors using p53Tumor suppressor gene. When DNA is damaged, p53 STOPS the cell from dividing until repairs are made. Or, if damage is too severe, p53 tells the cell to self-destruct (apoptosis). Break p53 and you remove the brake pad entirely..

Here's the problem: UVB also mutates p53 itself. So you get damaged DNA AND no editor to catch it. The cell divides. The daughter cells have the same mutation. This keeps happening for years until you get a clonal population of dysplastic keratinocytes sitting in the epidermis.

That clonal dysplastic population is the actinic keratosis.

🧬 The AK-to-SCC Story in One Chain

UV damages DNA in keratinocytes
→ UV also mutates p53 (the DNA repair cop)
→ Dysplastic cells divide unchecked (= AK)
→ More mutations accumulate over time
→ Cells break through the basement membrane (= invasive SCC)

Risk Factors

The profile is very specific

Risk Factor Why It Matters Board Clue
Chronic sun exposure Cumulative UVB damage over years (not single burn) Outdoor worker, farmer, landscaper, sailor
Fair skin (Fitzpatrick I-II) Less melanin = less UV protection Blue/green eyes, light hair, burns easily
Immunosuppression Immune surveillance fails, dysplastic cells aren't cleared Transplant patient on tacrolimus, HIV
Age >60 Decades of accumulated UV damage Combined with outdoor work = highest risk
Prior AK or skin cancer Same UV-damaged field produces more lesions Field cancerization (covered below)
🔐 The transplant patient on immunosuppressantsDrugs like tacrolimus, cyclosporine, and mycophenolate suppress T-cells to prevent rejection. But T-cells also patrol for and destroy pre-cancerous cells. Remove the patrol and dysplastic cells multiply unchecked. develops AK and SCC at dramatically higher rates. If you see "renal transplant patient" + skin lesion, think AK/SCC aggressively.

Clinical Features

Board exams test recognition. Know the feel.

Close view of actinic keratosis showing rough scaly texture
AK Close-up
Actinic keratoses on forehead
AK on Forehead
Squamous cell carcinoma progression from AK
SCC Progression
Actinic keratosis on the scalp
AK on Scalp

AK has a signature feel that earns it the nickname "sandpaper skin." The findings are:

FeatureDescriptionThe Clue
Texture Rough, gritty, sandpaper-like You can FEEL it before you see it on boards
Scale Adherent yellowish-white scale that recurs when removed "Comes back every time I pick it off"
Base Erythematous (red) base underneath the scale Remove scale → bleeding/red base = positive "flag sign"
Size Usually <1 cm Multiple lesions common, not just one
Location Sun-exposed areas: dorsal hands, face, scalp, ears, forearms, lips NEVER on covered skin
Symptoms Pruritus (itching), occasional burning/stinging Usually mild; painless unless irritated
⚠️
BOARD TRAP: When Does AK Become SCC?
Watch for features that suggest progression: rapid growth, induration (hardening of the base), ulceration, diameter >1 cm, or bleeding without provocation. Any of these = biopsy time. AK doesn't ulcerate or bleed spontaneously. SCC does.

Field Cancerization

Why treating one lesion isn't enough

Field cancerizationSlaughter's concept (1953): chronic carcinogen exposure (like UV) doesn't damage just one cell. It damages an entire field of cells in the exposed area. Multiple independent pre-malignant lesions develop across the field simultaneously. is the concept that explains why patients with one AK almost always have many. The entire sun-exposed area has been damaged by UV, not just the spot where the AK appeared.

Think of it like this: if you spill bleach on a carpet, the whole area is damaged, not just the visible stain. Treating only the visible AK without addressing the surrounding field leaves dozens of future lesions ready to emerge.

SUN-EXPOSED FIELD (e.g., dorsal hand) AK AK AK AK SCC (progressed) cryo here ...but field remains
Normal keratinocytes
Sub-clinical UV damage
Visible AK lesions
Progressed SCC

This is why dermatologists often use field therapy (5-FU cream, imiquimod) that treats the entire visible area, not just spot-treating each AK one by one. You have to treat the whole carpet, not just the stain you can see.

Sun Damage Progression

Tap each event to see what's happening at the cellular level

Normal Skin
tap for details
p53 intact and on duty. UVB damage happens daily but p53 catches the mutations and either repairs them or triggers apoptosis. Keratinocytes look normal under the microscope. No clinical lesions.
Cumulative UV Damage
tap for details
Years of sun exposure accumulate pyrimidine dimers faster than they can be repaired. p53 mutation rate increases. Some cells start dividing with damaged DNA. Still invisible clinically, but the field is already affected.
Actinic Keratosis
tap for details
Clonal expansion of dysplastic keratinocytes within the epidermis. p53 is mutated. Cells look abnormal on histology but are still above the basement membrane. Clinically: rough, scaly, erythematous patch. 5-10% SCC risk if untreated.
Bowen's Disease (SCC in situ)
tap for details
Full-thickness epidermal dysplasia. All cell layers involved. Still above the basement membrane (in situ = "in place"). Looks like a well-defined, slowly enlarging red scaly plaque. Higher SCC risk than AK. Often on trunk, genitals in addition to sun-exposed sites.
Invasive SCC
tap for details
Cells have broken through the basement membrane into the dermis. Now they can invade blood vessels and lymphatics. This is the cancer. It ulcerates, bleeds, and metastasizes (to regional lymph nodes first). Risk of death. This is why you treat AK early.
💡
AK vs Bowen's vs SCC: The One-Line Chain
AK = dysplastic lower epidermis only. Bowen's = dysplastic FULL-THICKNESS epidermis (but still in situ). Invasive SCC = broke through basement membrane. As you go down this list, prognosis worsens and treatment gets more aggressive.

Lesion ID Challenge

4 suspects walked into the clinic. Use the clues to eliminate the imposters.

A patient has a rough, sandpaper lesion on sun-exposed skin. These 4 diagnoses are on your differential. Use each clue to eliminate one at a time. Last one standing is the answer.

Seborrheic Keratosis
Benign, "stuck-on" waxy appearance
Basal Cell Carcinoma
Pearly, rolled border with telangiectasias
Psoriasis
Silver scale on extensor surfaces
Actinic Keratosis
Pre-malignant, UV-induced
Loading first clue...

The Full Differential

These get confused on boards. Know the key pattern for each.

Histopathology of actinic keratosis showing dysplastic keratinocytes
📷 AK histology · dysplastic lower epidermis · tap to expand
Condition Key Differentiator key pattern
AK Rough sandpaper texture, erythematous base, sun-exposed, adherent scale The feel is the clue. If it's rough and scaly on a sun-damaged area, it's AK until proven otherwise.
SCC Ulcerates, indurated, bleeds without provocation, bigger, faster growing AK doesn't bleed on its own. Bleeding = biopsy = SCC until proven otherwise.
BCC Pearly translucent nodule with rolled ("rodent") border and telangiectasias. Doesn't feel rough. BCC is smooth and shiny. AK is rough and scaly. If you feel glass vs sandpaper, you know which is which.
Bowen's Disease Well-defined, erythematous plaque. Full-thickness dysplasia (in situ SCC). On trunk, not just sun-exposed. Bowen's is SCC in situ (full-thickness). AK is partial thickness dysplasia. Bowen's also hits non-sun-exposed sites like trunk and genitals.
Seborrheic Keratosis "Stuck-on" waxy, verrucous appearance. Not always sun-exposed. Benign. Well-defined. Seb K is stuck ON the skin like someone applied it with glue. AK is IN the skin. Also: seb K is not pre-malignant, AK is.
Psoriasis Silver/white THICK scale. Symmetric. Extensor surfaces (elbows, knees). Auspitz sign positive. Systemic associations. Psoriasis is symmetric on elbows and knees. AK is asymmetric on sun-exposed areas. Nobody gets psoriasis "only on the dorsal hands" from being a landscaper.

The Lineup

Tap a card to flip it.

☀️
Actinic Keratosis
Pre-malignant, scaly rough papule

Actinic Keratosis

  • Mechanism: Cumulative UVB radiation, p53 mutation, dysplastic keratinocytes in epidermis that have NOT yet broken through the basement membrane
  • Presentation: Rough, scaly, erythematous papule or plaque on sun-damaged skin; better felt than seen ("sandpaper")
  • Treatment: Cryotherapy for isolated lesions; 5-fluorouracil or imiquimod for field treatment; PDT for face and recurrent
  • Board pearl: Pre-malignant lesion that can progress to SCC. Treat all of them. Field cancerization means one visible AK = many invisible dysplastic cells nearby.
🔴
Squamous Cell Carcinoma
AK gone invasive, Bowen = SCC in situ

Squamous Cell Carcinoma

  • Mechanism: Invasive malignant proliferation of epidermal keratinocytes; p53 mutation from UV; also from HPV, chronic wounds, arsenic
  • Presentation: Ulcerated, indurated, keratotic nodule on sun-damaged skin. Bowen disease = SCC in situ (full-thickness dysplasia, no invasion yet).
  • Treatment: Surgical excision. Mohs for high-risk locations (face, ears). Radiation for unresectable.
  • Board pearl: SCC metastasizes (unlike BCC). High-risk sites: lip, ear, genitalia. Marjolin ulcer: SCC arising in a chronic scar or burn.
🧷
Keratoacanthoma
Rapid growth, central keratin plug

Keratoacanthoma

  • Mechanism: Rapidly growing well-differentiated squamoproliferative lesion; UV-induced; some classify as a variant of SCC
  • Presentation: Rapidly enlarging dome-shaped nodule with central keratin-filled crater over weeks; most commonly on sun-exposed skin
  • Treatment: Excision is standard to exclude SCC histologically. Spontaneous regression occurs but cannot rely on it clinically.
  • Board pearl: Key board trap: spontaneously involutes, but you still excise it because histology cannot definitively distinguish from SCC without tissue.
🟫
Seborrheic Keratosis
Stuck-on, waxy, benign

Seborrheic Keratosis

  • Mechanism: Benign proliferation of immature keratinocytes; NOT UV-induced; NOT pre-malignant; common in older adults
  • Presentation: "Stuck-on" waxy, well-demarcated, tan-to-brown plaque; greasy texture; horn pseudocysts on dermoscopy
  • Treatment: None required. Cryotherapy or curettage if symptomatic or cosmetically bothersome.
  • Board pearl: Sign of Leser-Trelat: sudden eruption of multiple seborrheic keratoses = paraneoplastic sign of internal malignancy (especially GI adenocarcinoma).
🟤
Solar Lentigo
Benign age spot, not pre-malignant

Solar Lentigo

  • Mechanism: UV-induced increase in melanocytes and melanin in the basal layer; benign; no malignant potential
  • Presentation: Flat, uniformly brown macule on sun-exposed skin (dorsal hands, face); irregular but well-defined border; no papule or scale
  • Treatment: None required. Cosmetically, hydroquinone or laser treatment can lighten.
  • Board pearl: Completely benign. Distinguish from lentigo maligna (melanoma in situ): lentigo maligna has irregular variegated color and irregular border on face of elderly.

Treatment Decision Tree

Answer before you see the branch. It's the only way to learn it.

AK treatment depends on whether you're treating one visible lesion or the whole field. These require different approaches.

Patient has 2-3 discrete, clearly visible AK lesions. No evidence of SCC. What's your first-line local treatment?
A. Cryotherapy (liquid nitrogen)
B. 5-fluorouracil cream (5-FU)
C. Imiquimod cream
D. Photodynamic therapy (PDT)
Exactly right. Cryotherapy is the first-line for isolated, discrete lesions. Quick, precise, cost-effective. Liquid nitrogen destroys the dysplastic cells in seconds. Best when you can clearly see and target each lesion.
Good reasoning, but 5-FU is better for field therapy (treating a broad area of sun-damaged skin). For 2-3 discrete lesions, cryotherapy is faster and more targeted. But 5-FU is absolutely correct when there are many lesions or field cancerization is the concern.
Imiquimod is also a field treatment, not a spot treatment. It works by boosting local immune response to destroy dysplastic cells, but you'd apply it over a broad area, not dab it on 2-3 spots. Cryo is the spot treatment.
PDT is excellent but usually second-line or for larger/difficult-to-treat areas. It requires a photosensitizer (aminolevulinic acid) and a light source. For 2-3 simple lesions, cryotherapy is the practical first choice.

Decision branch: For isolated discrete AK → Cryotherapy. For widespread field with multiple AKs → 5-FU cream or Imiquimod (field treatment). For recurrent or complex cases → PDT. Bottom line: spot = cryo; field = topical therapy.

Your Treatment Toolkit

Know what each one does and when to reach for it

Treatment Trace It Best For Board Clue
Cryotherapy (liquid N2) Freezes and destroys dysplastic cells 1-3 discrete, clearly visible lesions Most common first-line for isolated AK
5-Fluorouracil (5-FU) cream Antimetabolite; kills rapidly dividing dysplastic cells Field treatment, multiple lesions over broad area Causes inflammation/crusting as it works (that's a good sign)
Imiquimod cream TLR-7 agonist; activates local immune response to destroy dysplastic cells Field treatment, immunocompetent patients Works via immune system; takes weeks; less useful in immunosuppressed
Photodynamic therapy (PDT) Topical photosensitizer (ALA) + light activation destroys abnormal cells Recurrent, extensive, cosmetically sensitive areas (face) Good cosmetic outcome; second-line for refractory cases
Diclofenac gel NSAID; anti-inflammatory + mild anti-proliferative Mild, limited AK in patients who can't tolerate other treatments Slowest-acting; least aggressive; for mild cases
Surgical excision Physical removal with margins Lesion suspicious for SCC; biopsy-confirmed malignancy If AK is changing, biopsy first, then excise if SCC confirmed

🧠 Memory Hook for Treatments

Cryotherapy = Choose this for isolated spots
F-U cream = Field treatment
Imiquimod = Immune-boosting field therapy
PDT = Premium option for face & recurrent
Diclofenac = Downscaled, for mild cases

🔐CFIPD: "Cryo First, Imiquimod Prevents Disease in fields" or just: spot = freeze it, field = cream it.

Clinical Vignettes

5 patients. All solar-damaged. Don't burn them.

Board-Style Walkthrough

Board-Style Walkthrough

Original board-style vignettes. Shuffled, never-repeat, full explanations for every choice.